Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early‐stage breast cancer

@article{Baum2003AnastrozoleAO,
  title={Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early‐stage breast cancer},
  author={M. Baum and A. Buzdar and J. Cuzick and J. Forbes and J. Houghton and A. Howell and T. Sahmoud},
  journal={Cancer},
  year={2003},
  volume={98}
}
The first analysis of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial (median follow‐up, 33 months) demonstrated that in adjuvant endocrine therapy for postmenopausal patients with early‐stage breast cancer, anastrozole was superior to tamoxifen in terms of disease‐free survival (DFS), time to recurrence (TTR), and incidence of contralateral breast cancer (CLBC). In the current article, the results of the first efficacy update, based on a median follow‐up period of 47 months, are… Expand
652 Citations
Exemestane following tamoxifen in postmenopausal women with primary breast cancer.
  • H. Mouridsen
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2004
  • 6
Review of the ATAC study: tamoxifen versus anastrozole in early-stage breast cancer
  • 6
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial.
  • 439
  • PDF
Anastrozole for breast cancer: recent advances and ongoing challenges
  • A. Buzdar
  • Medicine
  • Expert review of anticancer therapy
  • 2006
  • 4
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial.
  • 194
Changes in endocrine therapy: Anastrozole and advanced breast cancer in postmenopausal women
  • J. Nabholtz
  • Medicine
  • The American journal of hospice & palliative care
  • 2004
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 30 REFERENCES
Aromatase inhibitors for the endocrine adjuvant treatment of breast cancer
  • 12
Comprehensive cancer center.
  • 34
Academisch Ziekenhuis Rotterdam, locatie Daniel den Hoed
    Addenbrooke's NHS Trust Hospital
      Aultman Hospital Cancer Research Program
      • The Oncology Clinic PC
      Cancer Care Associates PC
      • Redwood Regional Medical Group
      Capelle a/d IJssel, The Netherlands; Dr. E. Maartense, Reinier de Graaf Gasthuis
        ...
        1
        2
        3
        ...